
|Podcasts|May 30, 2023
Health Equity Isn't a Theme, It's a Long-term Commitment
Advertisement
Wizdom Powell, PhD, MPH
Geetha Achanta, Scientific Director at OncLive
Tyrone Brewer, president of Janssen US Oncology
The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO 2022) focused on health equity. Even though it’s not this year’s theme for ASCO, at Janssen, health equity remains our focus year-round. Consistent commitment is how we achieve lasting systemic change. We must work together as a health care system – including pharma, health care practitioners (HCPs), payors, and more – to tackle the inherent biases in our care system, break down barriers to access, and build trust.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5

































































